Elizabeth Homans
Chief Executive Officer bei Immulus, Inc.
Vermögen: - $ am 31.03.2024
Profil
Elizabeth Homans is currently the Chief Executive Officer at Immulus, Inc. and also serves as the Director at Delfi Diagnostics, Inc. She was previously the Chief Executive Officer & Director at Lyell Immunopharma, Inc. and Executive Director-Project Leadership at Jazz Pharmaceuticals, Inc. Ms. Homans holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Bates College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
LYELL IMMUNOPHARMA, INC.
-.--% | 31.03.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Elizabeth Homans
Unternehmen | Position | Beginn |
---|---|---|
Immulus, Inc.
Immulus, Inc. Pharmaceuticals: MajorHealth Technology Immulus, Inc. provides bio manufacture cell therapies. The company was founded by Omar Ali and Alexander Cheung and is headquartered in Oakland, CA. | Chief Executive Officer | - |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delfi Diagnostics, Inc. engages in the development of blood test for detection and interception of cancer. It uses artificial intelligence and whole genome sequencing to detect patterns of DNA fragmentation in the blood of patients with cancer. The company is headquartered in Baltimore, MD. | Director/Board Member | 30.03.2022 |
Ehemalige bekannte Positionen von Elizabeth Homans
Unternehmen | Position | Ende |
---|---|---|
LYELL IMMUNOPHARMA, INC. | Chief Executive Officer | 15.12.2022 |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01.11.2007 |
Ausbildung von Elizabeth Homans
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Bates College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LYELL IMMUNOPHARMA, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delfi Diagnostics, Inc. engages in the development of blood test for detection and interception of cancer. It uses artificial intelligence and whole genome sequencing to detect patterns of DNA fragmentation in the blood of patients with cancer. The company is headquartered in Baltimore, MD. | Health Services |
Immulus, Inc.
Immulus, Inc. Pharmaceuticals: MajorHealth Technology Immulus, Inc. provides bio manufacture cell therapies. The company was founded by Omar Ali and Alexander Cheung and is headquartered in Oakland, CA. | Health Technology |